The lack of impact on outcomes was surprising, says the investigator, though the FAST-CTCA trial may still come through.

An intervention in rural China continued to impact hypertension, CV events, and dementia risk 4 years after it ended.

As the first TTVR trial to impact HF hospitalization and mortality, it “feels like a COAPT-like moment,” says Mohamad ...

The study supports a strategy of going wire-free for functional assessment in this setting and may well be “practice changing ...

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

SWITCH-SWEDEHEART’s unique design randomized healthcare regions but wasn’t a head-to-head comparison with ticagrelor.

While there was no change in disability-free survival, the results should impact guidelines, says François Mach.

Starting evolocumab in the cath lab before PCI did not, however, result in better clinical outcomes in the first year.

The CMR GUIDE trial didn’t meet its primary endpoint but did point to possible positives, especially in younger patients.

The US Food and Drug Administration has granted an expanded indication to tirzepatide (Mounjaro) for reducing major adverse ...